Perceptive Advisors LLC Adma Biologics, Inc. Transaction History

Perceptive Advisors LLC

$3 Billion
Q4 2024

A detailed history of Perceptive Advisors LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 890,280 shares of ADMA stock, worth $14.2 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

890,280

Previous 1,060,200 16.03%

Holding current value

$14.2 Million

Previous $21.2 Million 27.96%

% of portfolio

0.51%

Previous 0.55%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.62 - $22.62 $2.65 Million - $3.84 Million	-169,920 Reduced 16.03%	890,280 $15.3 Million
Q3 2024 Nov 14, 2024	SELL	$11.21 - $20.03 $19.2 Million - $34.3 Million	-1,710,800 Reduced 61.74%	1,060,200 $21.2 Million
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $21.9 Million - $40.9 Million	-3,662,369 Reduced 56.93%	2,771,000 $31 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $1.7 Million - $2.49 Million	-550,950 Reduced 7.89%	6,433,369 $29.1 Million
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $17.1 Million - $22.7 Million	-4,915,936 Reduced 41.31%	6,984,319 $25 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $2.39 Million - $3.75 Million	966,868 Added 8.84%	11,900,255 $46.2 Million
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $1.19 Million - $1.68 Million	-587,715 Reduced 5.1%	10,933,387 $26.6 Million
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $589,567 - $907,027	-412,285 Reduced 3.45%	11,521,102 $22.8 Million
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $1.45 Million - $2.21 Million	-1,328,988 Reduced 10.02%	11,933,387 $16.8 Million
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $3.75 Million - $5.48 Million	-3,322,427 Reduced 20.03%	13,262,375 $15 Million
Q1 2020 May 18, 2020	BUY	$1.5 - $4.59 $7.6 Million - $23.2 Million	5,063,700 Added 43.95%	16,584,802 $47.8 Million
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $17.6 Million - $26.2 Million	5,000,000 Added 76.67%	11,521,102 $44.6 Million
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $11.9 Million - $14.7 Million	2,700,000 Added 70.66%	6,521,102 $29.4 Million
Q4 2017 Feb 14, 2018	BUY	$2.06 - $3.24 $6.39 Million - $10 Million	3,100,000 Added 429.9%	3,821,102 $12.3 Million
Q3 2017 Nov 14, 2017	BUY	$2.76 - $3.71 $1.99 Million - $2.68 Million	721,102	721,102 $2.22 Million

Others Institutions Holding ADMA

# of Institutions

334

Shares Held

188M

Call Options Held

1.52M

Put Options Held

756K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.12B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Adma Biologics, Inc. Transaction History